Disease outcome and cytokine responses in cats immunized with an avirulent feline infectious peritonitis virus (FIPV)-UCD1 and challenge-exposed with virulent FIPV-UCD8

被引:48
作者
Kiss, I
Poland, AM
Pedersen, NC
机构
[1] Vet Inst Debrecen, H-4002 Debrecen, Hungary
[2] Univ Calif Davis, Sch Vet Med, Ctr Compan Anim Hlth, Davis, CA 95616 USA
关键词
D O I
10.1016/j.jfms.2003.08.009
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Eight cats were immunized with an avirulent strain of feline infectious peritonitis virus (FIPV)-UCD1, then challenge-exposed to a highly virulent cat passaged strain (FIPV-UCD8). Th1 and Th2 cytokine profiles in the peripheral blood mononuclear cells (PBMCs) were measured throughout in the experiment. No clinical signs of FIP were evident in the experimental cats after immunization. After challenge, the immunized cats demonstrated one of four clinical outcomes: (1) classical effusive FIP; (2) accelerated FIP; (3) non-effusive FIP, or (4) resistance to challenge. Only minor cytokine changes were observed following immunization, however, several cytokine changes occurred following challenge-exposure. The most noteworthy changes were in tumor necrosis factor-alpha (TNF-alpha) and interferon gamma (IFN-gamma) levels. Our preliminary findings suggest that immunity against FIP is associated with TNF-alpha and IFN-gamma response imbalance, with high TNF-alpha/low IFN-gamma mRNA responses favouring disease and low TNF-alpha/high IFN-gamma mRNA responses being indicative of immunity. (C) 2004 ESFM and AAFP. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:89 / 97
页数:9
相关论文
共 27 条
[11]   Murine coronavirus-induced subacute fatal peritonitis in C57BL/6 mice deficient in gamma interferon [J].
Kyuwa, S ;
Tagawa, YI ;
Shibata, S ;
Doi, K ;
Machii, K ;
Iwakura, Y .
JOURNAL OF VIROLOGY, 1998, 72 (11) :9286-9290
[12]   Acute hepatic failure in IFN-γ-deficient BALB/c mice after murine coronavirus infection [J].
Kyuwa, S ;
Shibata, S ;
Tagawa, Y ;
Iwakura, Y ;
Machii, K ;
Urano, T .
VIRUS RESEARCH, 2002, 83 (1-2) :169-177
[13]  
Kyuwa S, 1998, ADV EXP MED BIOL, V440, P445
[14]   Immunization of cats against feline immunodeficiency virus (FIV) infection by using minimalistic immunogenic defined gene expression vector vaccines expressing FIV gp140 alone or with feline interleukin-12 (IL-12), IL-16, or a CpG motif [J].
Leutenegger, CM ;
Boretti, FS ;
Mislin, CN ;
Flynn, JN ;
Schroff, M ;
Habel, A ;
Junghans, C ;
Koenig-Merediz, SA ;
Sigrist, B ;
Aubert, A ;
Pedersen, NC ;
Wittig, B ;
Lutz, H .
JOURNAL OF VIROLOGY, 2000, 74 (22) :10447-10457
[15]  
MCARDLE F, 1995, FELINE PRACT, V23, P67
[16]  
Pedersen N C, 1987, Adv Exp Med Biol, V218, P529
[17]  
PEDERSEN NC, 1989, ADV VET SCI COMP MED, V33, P413
[18]  
PEDERSEN NC, 1976, AM J VET RES, V37, P1449
[19]  
PEDERSEN NC, 1983, AM J VET RES, V44, P229
[20]  
PEDERSEN NC, 1995, FELINE PRACT, V23, P7